| scholarly article | Q13442814 |
| P2093 | author name string | Berhane Ghebrehiwet | |
| Prasad S Adusumilli | |||
| Afsar Barlas | |||
| Katia Manova-Todorova | |||
| Elisa de Stanchina | |||
| Xiaoyu Li | |||
| Qing Chang | |||
| Ning Fan | |||
| Yuquan Xiong | |||
| Ellinor Peerschke | |||
| Evelyn Kandov | |||
| Kenneth Stier | |||
| P2860 | cites work | Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. | Q50501479 |
| Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis. | Q52356762 | ||
| Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients. | Q53127385 | ||
| Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. | Q54579805 | ||
| Monoclonal antibodies in cancer therapy | Q84808389 | ||
| Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer | Q85890674 | ||
| Scientific Advances and New Frontiers in Mesothelioma Therapeutics | Q89390949 | ||
| Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy | Q91083896 | ||
| Mechanisms in the Pathogenesis of Asbestosis and Silicosis | Q22299314 | ||
| Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q | Q24315866 | ||
| Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001 | Q24817081 | ||
| The dual role of complement in cancer and its implication in anti-tumor therapy | Q26738682 | ||
| The hemopexin-like C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR | Q28214381 | ||
| Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells | Q31061802 | ||
| New p32/gC1qR Ligands for Targeted Tumor Drug Delivery | Q33694228 | ||
| An in vivo platform for tumor biomarker assessment | Q34064633 | ||
| Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 | ||
| Clinically useful monoclonal antibodies in treatment | Q34543634 | ||
| Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis | Q35067763 | ||
| Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity | Q35216278 | ||
| Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation. | Q35691775 | ||
| The C1q family of proteins: insights into the emerging non-traditional functions | Q35906624 | ||
| gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin | Q36085644 | ||
| C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation | Q36541076 | ||
| Soluble gC1qR in Blood and Body Fluids: Examination in a Pancreatic Cancer Patient Cohort | Q36673109 | ||
| Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma | Q36822118 | ||
| Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. | Q37139387 | ||
| Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis | Q37580348 | ||
| C1q as a unique player in angiogenesis with therapeutic implication in wound healing | Q37660089 | ||
| Increased breast cancer risk with HABP1/p32/gC1qR genetic polymorphism rs2285747 and its upregulation in northern Chinese women | Q37706725 | ||
| cC1qR/CR and gC1qR/p33: observations in cancer | Q38231962 | ||
| Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy | Q39612468 | ||
| Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma | Q39945573 | ||
| Estimation of the global burden of mesothelioma deaths from incomplete national mortality data. | Q40060134 | ||
| Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma | Q42563176 | ||
| In vitro and in vivo adherence of tumor cell variants correlated with tumor formation. | Q42735463 | ||
| Increased expression of hyaluronic acid binding protein 1 is correlated with poor prognosis in patients with breast cancer. | Q45946756 | ||
| Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth. | Q47095454 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1413 | |
| P577 | publication date | 2020-08-12 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma | |
| P478 | volume | 10 |
Search more.